Intention to apply quality measures to practice 50 87 37
Self-reported "excellent" ability to make evidencebased treatment and management decisions 64 80 16
"Very likely" to simplify treatment regimens before escalating therapies 50 100 50
Perception of side effects as "very significant" barrier 50 33 a 17
Lack of familiarity with new treatments as "very significant" barrier 50 40 a 10
Lack of familiarity with practice guidelines as "very significant" barrier 36 20 a 16 a Lower post-activity score indicates less impact of perceived barrier
